Skip to content

Enhanced CJD Surveillance in the Older Population

Enhanced CJD Surveillance in the Older Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02629640
Enrollment
30
Registered
2015-12-14
Start date
2016-01-19
Completion date
2022-03-31
Last updated
2024-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, Prion Disease

Keywords

vCJD, prion disease, dementia, old-age, surveillance, brain banking, public health

Brief summary

The purpose of this study to investigate if cases of Creutzfeldt-Jakob Disease (CJD) and other forms of prion disease are being missed in older adults living within Lothian.

Detailed description

The study involves patients aged 65 years or over who have been seen by a neurologist or psycho-geriatrician and identified as having features that are atypical for the known types of dementia. All patients will be invited to an initial meeting with the research team to discuss the study and, if they agree to participate, for clinical assessment and epidemiological review. Participants will be asked to donate blood or a buccal sample for codon-129 polymorphism genotyping and may be offered a MRI brain scan if no such imaging has been previously undertaken. Participants will also be asked to consider if, in the event of their death, they would donate samples of brain tissue to the Edinburgh Brain Bank for use in this and future research. Telephone follow up will be offered within 1 month of joining the study and at 3 monthly intervals thereafter, with further clinical review offered if deemed appropriate.

Interventions

OTHERMedical history questionnaire

Epidemiological review of past medical/dental history; residential history; occupational history; family history of neurodegenerative disease.

OTHERClinical assessment and review

History of current illness; neurological examination including general appearance, full cognitive assessment and physical examination; MRI research brain scan.

Hospital patient management system; regular telephone contact with patient/representative.

OTHERBlood or buccal sample

Codon-129 genotyping; storage for future research.

OTHERPost mortem examination

Brain tissue donation to the Edinburgh Brain and Tissue Bank for research,including investigations for evidence of prion disease.

Sponsors

NHS Lothian
CollaboratorOTHER_GOV
Department of Health, United Kingdom
CollaboratorOTHER_GOV
University of Edinburgh
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 65 years or above * Patients accessing NHS Lothian neurology and psychogeriatric services * Patients who have features atypical for the recognised forms of dementia * Appropriate informed consent

Exclusion criteria

* Patients aged below 65 at time of recruitment * Patients diagnosed with a clear alternative demonstrable pathology

Design outcomes

Primary

MeasureTime frame
Evidence of prion disease pathology in the Lothian population, a description of the associated clinical/pathological and epidemiological features and referral characteristics, and how this compares with other cases of prion disease.4.5 years

Secondary

MeasureTime frame
Description of clinical, pathological and epidemiological characteristics of patients with atypical features of dementia in the Lothian population.4.5 years
Assessment of the suitability of methods to support an extended system of enhanced CJD surveillance in the rest of the UK.4.5 years

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026